Nutra Pharma Begins Drug Registration Process In Central America For Its Nyloxin Pain Reliever
Posted Jun 24 2010 12:00am
June 24, 2010
Nutra Pharma Has Begun the Drug Registration Process in Panama for Its Nyloxin Pain Reliever
Coral Springs, FL (Marketwire) - Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), announced today that it has begun the drug registration process in Panama for its Nyloxin pain reliever.
"As an important international business center, Panama offers us an opportunity to introduce our Nyloxin pain reliever in Central America," explained Rik J Deitsch, Chairman and CEO of Nutra Pharma. "We plan to move forward with this drug registration process in conjunction with finalizing our relationship with a prospective local distribution partner that has the resources and capabilities to successfully market and distribute Nyloxin throughout the country," he concluded.
*